Table 4.
Cases | Controls | OR* | Adjusted OR† | p Value | |
---|---|---|---|---|---|
Main analysis | |||||
VTE | |||||
Non-carrier | 125 | 1369 | 1.00 | 1.00 | – |
Carrier | 55 | 406 | 1.55 (1.09 to 2.21) | 1.78 (1.18 to 2.69) | 0.006 |
DVT only | |||||
Non-carrier | 83 | 841 | 1.00 | 1.00 | – |
Carrier | 24 | 207 | 1.18 (0.71 to 1.95) | 1.43 (0.79 to 2.59) | 0.2 |
PE | |||||
Non-carrier | 36 | 449 | 1.00 | 1.00 | – |
Carrier | 26 | 170 | 2.09 (1.17 to 3.72) | 2.27 (1.17 to 4.39) | 0.011 |
Subgroup analysis | |||||
VTE definition included anticoagulant therapy, clinic attendance or death | |||||
Non-carrier | 60 | 725 | 1.00 | 1.00 | – |
Carrier | 36 | 223 | 2.20 (1.36 to 3.57) | 2.71 (1.52 to 4.83) | 0.001 |
*Matched by age and sex.
†Adjusted for age, sex, pregnancy, BMI, smoking status and ethnicity.